Trial Profile
TUHRS study - Teriparatide Use in Hip Replaced Subjects a pilot study on the use of teriparatide in severe osteoporotic women with hip fracture and submitted to hip replacement
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 Oct 2021
Price :
$35
*
At a glance
- Drugs Teriparatide (Primary)
- Indications Postmenopausal osteoporosis
- Focus Therapeutic Use
- Acronyms TUHRS
- Sponsors Eli Lilly and Company
- 29 Aug 2006 Status change
- 26 Nov 2005 New trial record.